Automated blood coagulation, hemostasis testing analyzer reagents supplies

Active Indefinite Delivery Contract Awarded Last action

Contract number
W91YTZ25DA002
Awardee
Awarding agency
Task orders
2 $118,345 obligated

Award facts

Combined order value
$118,345 Current and potential, with all options
Last date to order 29% complete
IDV ceiling 14% used
$847,255.81
Maximum order
$200,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency awarded a single-award indefinite-delivery contract to Werfen USA LLC on May 1, 2025, with a ceiling of $847,255.81 for automated blood coagulation, hemostasis testing analyzer reagents and supplies, with ultimate completion on April 30, 2030.

No set-aside was used. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory instrumentation, competes without small business designations.

Place of performance includes North Carolina locations where Defense Health Agency medical treatment facilities operate, including Fayetteville and Faison.

The IDIQ was established to supply coagulation testing analyzers, reagents, and consumables to support the Department of Defense's healthcare delivery operations. Period of performance runs from May 1, 2025 through April 30, 2030.

Recent delivery orders issued under this IDIQ include a $108,657.52 firm fixed-price delivery order for blood coagulation analyzer and reagents at Fayetteville, North Carolina, with performance from October 1, 2025 through September 30, 2026, and a $9,687.87 delivery order for blood coagulation analyzer and reagents at Faison, North Carolina, completed by September 30, 2025. Both orders carry firm fixed-price pricing.

Task orders

Task order Ordering agency Obligated Awarded
Blood coagulation analyzer and reagents do/to W81K0425FA238 Medical Command (Army) $108,658
VGM FY25 do blood coag analyzer and reagents wamc W91YTZ25FA120 Medical Command (Army) $9,688

Transactions

Action Obligated Date
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract W91YTZ25DA002?

W91YTZ25DA002 was awarded to Werfen USA LLC by Medical Command (Department of the Army) on May 1, 2025.

How much is contract W91YTZ25DA002 worth?

Orders under W91YTZ25DA002 have obligated $118,345. W91YTZ25DA002's own ceiling is $847,256. A single order can be worth up to $200,000.

How many orders have been placed under contract W91YTZ25DA002?

2 orders have been placed under W91YTZ25DA002, the latest on October 1, 2025.

Which agency awarded contract W91YTZ25DA002?

Medical Command (Department of the Army) awarded W91YTZ25DA002, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W91YTZ25DA002?

W91YTZ25DA002 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W91YTZ25DA002 competed?

The extent of competition for W91YTZ25DA002 was competed under sap. The government received 2 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV